In these situa-tions, care should not be delayed. Anesthesiologists Have the Final Say Following the AGA clinical update, Ali Rezaie, MD, director of the GI motility program at Cedars Sinai in Los Angeles, recalled there being tension among all those involved in managing preoperative care for GLP-1 users
Perhaps we should assess whether, in people with diabetes, high cardiovascular risk, and chronic low-grade inflammation, this type of treatment might have some benefit
In this scenario, a highly virulent disease (like rabies) may be able to cause significant damage or death before the immune system has learned how to effectively fight it
doi:10.3109/15563659709001226 132 Shahin, A
doi: 10.1097/CCM.0000000000004289 105 CaturegliGChoSMWhiteBChenLL